<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03682315</url>
  </required_header>
  <id_info>
    <org_study_id>307CEIH2017</org_study_id>
    <nct_id>NCT03682315</nct_id>
  </id_info>
  <brief_title>Comparison of Phicogenic vs. Xenogeneic Biomaterial for Maxillary Sinus Floor Elevation</brief_title>
  <official_title>Algae-derived Hydroxyapatite Behaviour as Bone Biomaterial in Comparison to Anorganic Bovine Bone. A Randomised Split-mouth Human Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad de Granada</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad de Granada</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to evaluate the clinical and radiological behavior, the histological and
      morphometrical components, the expression of proteins related to bone formation, and the
      analysis of markers of reparative mesenchymal stromal cells, after using a biphasic
      phicogenic biomaterial in comparison with anorganic bovine bone.

      A randomized split-mouth clinical study is designed to include patients in need of two-stage
      bilateral maxillary sinus floor elevation. Patients are assigned to receive a mix of
      autogenous bone and a biphasic phycogenic biomaterial in one maxillary sinus and a mix of
      autogenous bone and xenograft bovine hydroxyapatite in the other maxillary sinus. Cone-beam
      computerized tomography (CBCT) scans are performed before sinus floor elevation and 6 months
      after the procedure to assess the bone gain. Bone core biopsies are obtained at the site of
      implant placement 6 months after the floor elevation. Histological sections are subjected to
      histomorphometric and immunohistochemical evaluation of differentiation markers.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2016</start_date>
  <completion_date type="Actual">May 2018</completion_date>
  <primary_completion_date type="Actual">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sinus floor height change</measure>
    <time_frame>From surgery to 6 months</time_frame>
    <description>CBCT scans are performed before the sinus floor elevation and 6 months later before implant placement to calculate vertical bone height change from the crestal bone to the floor of the maxillary sinus</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Area of new mineralized tissue</measure>
    <time_frame>6 months</time_frame>
    <description>Histomorphometric quantification of new mineralized tissue in a bone biopsy collected 6 months after the grafting procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area of non-mineralized tissue</measure>
    <time_frame>6 months</time_frame>
    <description>Histomorphometric quantification of non-mineralized tissue in a bone biopsy collected 6 months after the grafting procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area of remaining graft particles</measure>
    <time_frame>6 months</time_frame>
    <description>Histomorphometric quantification of remaining graft particles in a bone biopsy collected 6 months after the grafting procedure</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>Sinus Floor Augmentation</condition>
  <arm_group>
    <arm_group_label>Biphasic phycogenic biomaterial</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Biphasic phycogenic biomaterial and Autogenous cortical bone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Xenograft bovine hydroxyapatite</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Xenograft bovine hydroxyapatite and Autogenous cortical bone</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Biphasic phycogenic biomaterial</intervention_name>
    <description>Maxillary sinus floor elevation and bone grafting with the use of biphasic phycogenic biomaterial combined with autogenous cortical bone</description>
    <arm_group_label>Biphasic phycogenic biomaterial</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Xenograft bovine hydroxyapatite</intervention_name>
    <description>Maxillary sinus floor elevation and bone grafting with the use of xenograft bovine hydroxyapatite combined with autogenous cortical bone</description>
    <arm_group_label>Xenograft bovine hydroxyapatite</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Partially edentulous patients.

          -  Kennedy class I in the upper jaw.

          -  Less than 5 mm of residual crestal bone to the maxillary sinus.

          -  Need for the replacement of teeth with dental implants.

        Exclusion Criteria:

          -  Sinus pathology (sinusitis, mucocele, cysts).

          -  Smokers.

          -  Previous long-term (&gt;3 months) use of drugs known to affect bone metabolism, such as
             bisphosphonates.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pablo Galindo-Moreno, DDS, PhD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad de Granada</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Facultad de Odontología</name>
      <address>
        <city>Granada</city>
        <zip>18071</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Galindo-Moreno P, Hernández-Cortés P, Mesa F, Carranza N, Juodzbalys G, Aguilar M, O'Valle F. Slow resorption of anorganic bovine bone by osteoclasts in maxillary sinus augmentation. Clin Implant Dent Relat Res. 2013 Dec;15(6):858-66. doi: 10.1111/j.1708-8208.2012.00445.x. Epub 2012 Feb 29.</citation>
    <PMID>22376122</PMID>
  </reference>
  <reference>
    <citation>Galindo-Moreno P, Avila G, Fernández-Barbero JE, Aguilar M, Sánchez-Fernández E, Cutando A, Wang HL. Evaluation of sinus floor elevation using a composite bone graft mixture. Clin Oral Implants Res. 2007 Jun;18(3):376-82. Epub 2007 Mar 12.</citation>
    <PMID>17355356</PMID>
  </reference>
  <reference>
    <citation>Galindo-Moreno P, de Buitrago JG, Padial-Molina M, Fernández-Barbero JE, Ata-Ali J, O Valle F. Histopathological comparison of healing after maxillary sinus augmentation using xenograft mixed with autogenous bone versus allograft mixed with autogenous bone. Clin Oral Implants Res. 2018 Feb;29(2):192-201. doi: 10.1111/clr.13098. Epub 2017 Oct 26.</citation>
    <PMID>29071736</PMID>
  </reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>September 21, 2018</study_first_submitted>
  <study_first_submitted_qc>September 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2018</study_first_posted>
  <last_update_submitted>April 15, 2020</last_update_submitted>
  <last_update_submitted_qc>April 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad de Granada</investigator_affiliation>
    <investigator_full_name>Pablo Galindo-Moreno</investigator_full_name>
    <investigator_title>Full Professor of Oral Surgery and Implant Dentistry</investigator_title>
  </responsible_party>
  <keyword>Maxillary sinus augmentation</keyword>
  <keyword>Sinus lift</keyword>
  <keyword>Biomaterial</keyword>
  <keyword>Anorganic bovine bone</keyword>
  <keyword>Phicogenic biomaterial</keyword>
  <keyword>Implant Dentistry</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

